News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Laura Bukavina: Clear failure of clinical trials to represent the true population of Genitourinary cancer patients
Photo from Laura Bukavina/X
Jun 24, 2024, 02:32

Laura Bukavina: Clear failure of clinical trials to represent the true population of Genitourinary cancer patients

Laura Bukavina, Urologic Oncologist at Cleveland Clinic, shared on X:              .

“Our new study reveals a clear failure of clinical trials to represent the true population of Genitourinary (GU) cancer patients. By not adequately including older adults, the efficacy and toxicity of many treatments appear falsely reassuring.

Read here.”

Laura Bukavina: Clear failure of clinical trials to represent the true population of Genitourinary cancer patients

Source: Laura Bukavina/X

bladder cancer cancer Cleveland Clinic clinical trials failure of clinical trials Genitourinary Cancer kidney cancer Laura Bukavina OncoDaily Oncology prostate cancer Urologic Oncologist
Special Coverage
Blog Posts
Aug 18, 2025, 18:20
Amol Akhade: Key Late-Breaking and Practice-Changing Trials to Watch at WCLC 2025
Insight
Aug 18, 2025, 18:09
Hung Trinh Highlights Pasritamig, a First-in-Class T-Cell Engager for Prostate Cancer
Voices
Aug 18, 2025, 17:43
Building a Healthier Future for Women Also Means Building a Healthier Future for the Next Generation - Elekta Foundation
Voices
Aug 18, 2025, 17:35
Mandar Muzumdar: The Evolution of Single-Cell 3D Genomes in KRAS-Driven Cancers
Blog Posts
Aug 18, 2025, 17:21
Douglas Flora: Create the Things You Wish Existed
Blog Posts
Aug 18, 2025, 17:13
Matt Yurgelun: Thrilled to Be Joining The Jimmy Fund Radio-Telethon
Voices
Aug 18, 2025, 17:04
Striking out Cancer for Patients Like Charlie - The Jimmy Fund
Insight
Aug 18, 2025, 16:52
Darren Haywood: Pleased to Receive COSA Endorsement of the MASCC COG-IMPACT Tool
Science
Aug 18, 2025, 16:48
Petros Grivas: Highlighting Intra-Patient Tumor Heterogeneity in Prostate Cancer Research
Science
Aug 18, 2025, 16:46
How Do We Select the Best 2L Therapy for Advanced EGFR‑Mutant NSCLC After Osimertinib? - Oncogene Cancer Research
Blog Posts
Aug 18, 2025, 16:37
Amanda Impellizzeri: What a Weekend at the Carolina Cancer Conference
Science
Aug 18, 2025, 16:33
Maria Tolia: New Study on Cardio-Oncology Considerations for Breast Cancer